Questioning the assumptions about type 2 diabetes

Lipscombe, Lorraine L.; Detsky, Allan S.
August 2014
CMAJ: Canadian Medical Association Journal;8/5/2014, Vol. 186 Issue 11, p880
Academic Journal
The article discusses the assumptions that are the basis of clinical practice guidelines for type 2 diabetes which resulted to an increase in the number of patients receiving multiple lifelong therapies. Topics discussed include one assumption that type 2 diabetes is a progressive and irreversible disease diagnosed on the basis of blood glucose and another assumption that people who receive a diagnoses of type 2 diabetes will benefit from therapies that lower glucose levels.


Related Articles

  • Two-Step Approach for the Prediction of Future Type 2 Diabetes Risk. ABDUL-GHANI, MUHAMMAD A.; ABDUL-GHANI, TAMAM; STERN, MICHAEL P.; KARAVIC, JASMINA; TUOMI, TIINAMAIJA; BO, INSOMA; DEFRONZO, RALPH A.; GROOP, LEIF // Diabetes Care;Sep2011, Vol. 34 Issue 9, p2108 

    OBJECTIVE--To develop a model for the prediction of type 2 diabetes mellitus (T2DM) risk on the basis of a multivariate logistic model and 1-h plasma glucose concentration (1-h PG). RESEARCH DESIGN AND METHODS--The model was developed in a cohort of 1,562 nondiabetic subjects from the San...

  • Differential Effects of Comorbidity on Antihypertensive and Glucose-Regulating Treatment in Diabetes Mellitus - A Cohort Study. Voorham, Jaco; Haaijer-Ruskamp, Flora M.; Wolffenbuttel, Bruce H. R.; Dick de Zeeuw; Stolk, Ronald P.; Petra Denig // PLoS ONE;Jun2012, Vol. 7 Issue 6, p1 

    Background: Comorbidity is often mentioned as interfering with "optimal" treatment decisions in diabetes care. It is suggested that diabetes-related comorbidity will increase adequate treatment, whereas diabetes-unrelated comorbidity may decrease this process of care. We hypothesized that these...

  • Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72). Clarke, P.M.; Gray, A.M.; Briggs, A.; Stevens, R.J.; Matthews, D.R.; Holman, R.R. // Diabetologia;May2005, Vol. 48 Issue 5, p868 

    Aims/hypothesis: This study estimated the economic efficiency (1) of intensive blood glucose control and tight blood pressure control in patients with type 2 diabetes who also had hypertension, and (2) of metformin therapy in type 2 diabetic patients who were overweight. Methods: We conducted...

  • Are you at risk of T-2 diabetes? CHUA, PHILIP S. // Filipino Reporter;3/1/2013, Vol. 41 Issue 13, p35 

    The article presents questions and answers related to diabetes including its risk factors, the monitoring of blood sugar levels, and whether type 2 diabetes is preventable.

  • Point: a glucose tolerance test is important for clinical practice. Tuomilehto, Jaakko // Diabetes Care;Oct2002, Vol. 25 Issue 10, p1880 

    Focuses on the importance of glucose tolerance tests in clinical practice. Report that asymptomatic diabetes increases the risk of cardiovascular disease and all-cause mortality; Determination of hyperglycemia; Discussion of screening for blood glucose among high risk patients; Problems with...

  • Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Petersen, Kitt Falk; Dufour, Sylvie; Befroy, Douglas; Lehrke, Michael; Hendler, Rosa E.; Shulman, Gerald I. // Diabetes;Mar2005, Vol. 54 Issue 3, p603 

    To examine the mechanism by which moderate weight reduction improves basal and insulin-stimulated rates of glucose metabolism in patients with type 2 diabetes, we used (1)H magnetic resonance spectroscopy to assess intrahepatic lipid (IHL) and intramyocellular lipid (IMCL) content in conjunction...

  • Size and Timing of Postmeal Glucose Peaks in Every Day Life of Type 2 Diabetic Patients. The Capri Experience. Esposito, Katherine; Ceriello, Antonio; Giugliano, Dario // Diabetes;Jun2007 Supplement 1, Vol. 56, pA174 

    Context: Two-hour postprandial hyperglycemia is related to chronic complications of diabetes and is currently used to describe postmeal glycemic peaks. Objective: To assess size and timing of postmeal glucose peaks in every day life of type 2 diabetic patients, the relationship with carotid...

  • Controlling Blood Glucose Levels in Patients with Type 2 Diabetes Mellitus. Woolf, Steven H.; Davidson, Mayer B.; Greenfield, Sheldon; Bell, Hanan S.; Ganiats, Theodore G.; Hagen, Michael D.; Palda, Valerie Anne; Rizza, Robert A.; Spann, Stephen J. // Journal of Family Practice;May2000, Vol. 49 Issue 5, p453 

    OBJECTIVE: To review evidence about the benefit of intensive glycemic control for patients with type 2 diabetes and to develop practice recommendations. PARTICIPANTS: A 9-member panel composed of family physicians, general internists, endocrinologists, and a practice guidelines methodologist was...

  • Macrovascular Risk and Diagnostic Criteria for Type 2 Diabetes. Jesudason, David R.; Dunstan, Kerrie; Dunstan, Kerri; Leong, Darryl; Wittert, Gary A. // Diabetes Care;Feb2003, Vol. 26 Issue 2, p485 

    OBJECTIVE — The use of fasting plasma glucose (FPG) level ≥ 7.0 mmol/l leads to underdiagnosis of type 2 diabetes compared with the oral glucose tolerance test (OGTT). The OGTT is of limited use for population screening. Most of the increase in cardiovascular risk in relation to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics